louisiana semaglutide gastric stasis legal team gastrointestinal obstruction FDA updates Ozempic label to acknowledge some users' reports of blocked intestines Weight-Loss Drug Stomach Paralysis Lawsuit

Topical products do not prevent the systemic trigger but can support regrowth, says Dr

Screening for coronary artery disease is not recommended in asymptomatic individuals if ASCVD risk factors are adequately treated

When semaglutide is combined with insulin or sulfonylureas without dose adjustment, hypoglycemia rates rise significantly, which is why dose reduction of those other drugs is critical when starting GLP-1 therapy

Mom frees up

This could lead to situations where patients may also misattribute symptoms to their illicit GLP-1 medication, potentially missing the early diagnosis and treatment of unrelated illnesses, and as a result, poorer health outcomes for patients and increased costs to the NHS

The evidence is there